Summary ORs and 95%CIs of the association between <i>IL-1RN VNTR</i> polymorphism and CHD risk.

<p><i>Notes</i> OR, odds ratio; CI, confidence interval; <i>P</i>_H,<i>P</i> value based on Q test for between-study heterogeneity; HWE =  Hardy–Weinberg equilibrium;</p><p>CHD = coronary artery disease; ACS = acute coronary syndrome; MI = myocardial infarction; PB, Population-based; HB, Hospital-based.</p

Meta-analysis of the association between <i>IL-1B +3954</i> polymorphism and CHD risk (T vs. C).

<p>Meta-analysis of the association between <i>IL-1B +3954</i> polymorphism and CHD risk (T vs. C).</p

Selection of articles for inclusion in meta-analysis.

<p>Selection of articles for inclusion in meta-analysis.</p

Summary ORs and 95%CIs of the association between <i>IL-1B +3954</i> polymorphism and CHD risk.

<p><i>Notes</i> OR, odds ratio; CI, confidence interval; <i>P</i>_H,<i>P</i> value based on Q test for between-study heterogeneity; HWE =  Hardy–Weinberg equilibrium;</p><p>CHD = coronary artery disease; ACS = acute coronary syndrome; MI = myocardial infarction; PB, Population-based; HB, Hospital-based.</p

Meta-analysis of the association between <i>IL-1B -511</i> polymorphism and CHD risk (T vs. C).

<p>Meta-analysis of the association between <i>IL-1B -511</i> polymorphism and CHD risk (T vs. C).</p

Characteristics of studies included in the meta-analysis.

<p><i>Notes</i> For <i>IL-1B-511</i> and <i>IL-1B+3954</i> polymorphisms, 11 = CC, 12 = CT, 22 = TT; for <i>IL-1RN VNTR</i> polymorphism, 11 = L/L, 12 = *2/L, 22 = *2/*2;</p><p>PB, Population-based; HB, Hospital-based; NA, not available;</p>a<p>, <i>p</i> value for Hardy-Weinberg equilibrium in controls; ^b, allele represented by 1; ^c, allele represented by 2;</p><p>CHD = coronary artery disease; ACS = acute coronary syndrome; MI = myocardial infarction.</p